Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTP2HE5)

DTT Name	Tumor associated calcium signal transducer 2 (TACSTD2) DTT Info
Gene Name	TACSTD2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Sacituzumab govitecan	DMUWFD8	Breast cancer	2C60-2C65	Approved	[1]
------------------------------------------------------------------------------------

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
SKB264	DMSTEFK	Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[2]
------------------------------------------------------------------------------------

1 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
YH012	DMG3WBJ	Aggressive cancer	2A00-2F9Z	Investigative	[3]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Sacituzumab Govitecan: First Approval. Drugs. 2020 Jul;80(10):1019-1025.
2	ClinicalTrials.gov (NCT04152499) Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (A264). U.S. National Institutes of Health.
3	Clinical pipeline report, company report or official report of Biocytogen